REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Ensu Lifesciences Sdn. Bhd. (Malaysia)

Main Activities: Toilet Preparation Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers | Truck Transportation
Full name: Ensu Lifesciences Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Manufacture of perfumes and toilet preparations; manufacture of other pharmaceuticals, medicinal chemical and botanical products n.e.c; freight transport by road

Headquarters
No 47, Jalan Kp3, Kawasan Perindustrian Kota Puteri
Batu Arang; Selangor; Postal Code: 48100

Contact Details: Purchase the Ensu Lifesciences Sdn. Bhd. report to view the information.

Website: http://www.ensu.com.my

Basic Information
Outstanding Shares:
Purchase the Ensu Lifesciences Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Ensu Lifesciences Sdn. Bhd. report to view the information.
Incorporation Date:
February 17, 2016
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
51%
Purchase this report to view the information.
49%
Company Performance
Financial values in the chart are available after Ensu Lifesciences Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
56.4%▲
Total operating revenue
56.4%▲
Operating profit (EBIT)
-57.47%▼
EBITDA
-28.14%▼
Net Profit (Loss) for the Period
-36.52%▼
Total assets
47.92%▲
Total equity
152.08%▲
Operating Profit Margin (ROS)
-7.3%▼
Net Profit Margin
-3.84%▼
Return on Equity (ROE)
-89.35%▼
Debt to Equity Ratio
-303.12%▼
Quick Ratio
0.1%▲
Cash Ratio
0.12%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo